Roche And Biogen Settle Patent Row Over Arthritis Biosimilar - Law360

Roche And Biogen Settle Patent Row Over Arthritis Biosimilar – Law360

Source Node: 2345109
By Henrik Nilsson (October 23, 2023, 11:12 PM EDT) — Pharmaceutical company Hoffmann-La Roche Inc. has settled a patent lawsuit alleging that Biogen MA Inc.’s proposed similar version of Roche’s rheumatoid arthritis drug Actemra infringed several patents, according to a joint stipulation of dismissal filed Monday in Massachusetts federal court….

Time Stamp:

More from Law 360